nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Atrial fibrillation and type 1 diabetes
|
Li, Qianrui |
|
2017 |
5 |
12 |
p. 936 |
artikel |
2 |
Atrial fibrillation and type 1 diabetes
|
Xiao, Ying |
|
2017 |
5 |
12 |
p. 936-937 |
artikel |
3 |
Atrial fibrillation and type 1 diabetes – Authors' reply
|
Lind, Marcus |
|
2017 |
5 |
12 |
p. 937 |
artikel |
4 |
Cardiovascular risk after cessation of growth hormone treatment in people born small for gestational age
|
Pivonello, Rosario |
|
2017 |
5 |
12 |
p. 930-932 |
artikel |
5 |
Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study
|
van der Steen, Manouk |
|
2017 |
5 |
12 |
p. 975-985 |
artikel |
6 |
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
|
Sabatine, Marc S |
|
2017 |
5 |
12 |
p. 941-950 |
artikel |
7 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 963–64
|
|
|
2017 |
5 |
12 |
p. e8 |
artikel |
8 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 1004–16
|
|
|
2017 |
5 |
12 |
p. e8 |
artikel |
9 |
Correction to Lancet Diabetes Endocrinol 2017; 5: 864–76
|
|
|
2017 |
5 |
12 |
p. e8 |
artikel |
10 |
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
|
Ueki, Kohjiro |
|
2017 |
5 |
12 |
p. 951-964 |
artikel |
11 |
Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials
|
Autier, Philippe |
|
2017 |
5 |
12 |
p. 986-1004 |
artikel |
12 |
Fat: so much more than just fat
|
Stirrups, Robert |
|
2017 |
5 |
12 |
p. 940 |
artikel |
13 |
Good value care: when less is more
|
The Lancet Diabetes & Endocrinology, |
|
2017 |
5 |
12 |
p. 925 |
artikel |
14 |
How can we optimise diabetes care in real-world practice?
|
Chan, Juliana C N |
|
2017 |
5 |
12 |
p. 927-929 |
artikel |
15 |
How to address non-communicable diseases in urban Africa
|
Hunter-Adams, Jo |
|
2017 |
5 |
12 |
p. 932-934 |
artikel |
16 |
Linoleic acid and risk of type 2 diabetes
|
Riccardi, Gabriele |
|
2017 |
5 |
12 |
p. 929-930 |
artikel |
17 |
Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies
|
Wu, Jason H Y |
|
2017 |
5 |
12 |
p. 965-974 |
artikel |
18 |
PCSK9 inhibition and type 2 diabetes
|
Lotta, Luca A |
|
2017 |
5 |
12 |
p. 926-927 |
artikel |
19 |
Research digest: hypoglycaemia and glucose variability
|
Sattar, Naveed |
|
2017 |
5 |
12 |
p. 938 |
artikel |
20 |
Top ten research priorities for type 2 diabetes: results from the Diabetes UK–James Lind Alliance Priority Setting Partnership
|
Finer, Sarah |
|
2017 |
5 |
12 |
p. 935-936 |
artikel |
21 |
transCampus London–Dresden: a new model for international collaborative research
|
Mitchell, Fiona |
|
2017 |
5 |
12 |
p. 939 |
artikel |